JESSICA HORWATH: Open Payments
NPI 1083853246 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 18 payments from 12 companies in 2025. Trend: 2023 $394 · 2024 $315 · 2025 $673
Food & beverage: $578Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $150 |
| Botanix SB Inc | 1 | $126 |
| Incyte Corporation | 1 | $111 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Genentech USA, Inc. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Organon LLC | 1 | $22 |
Products named: DUPIXENT, SOFDRA, Opzelura, NEFFY, Xolair, INSPIRE, TEZSPIRE, NUCALA.
Industry payments across TX — which companies pay providers there.
